The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV
Abstract Background Drug-related mortality in the United States continues to transform, marked by a surge in overdose deaths involving both fentanyl and stimulants. This pattern presents specific risks for people at risk for and living with HIV, who have high rates of stimulant use and disproportion...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-12-01
|
| Edice: | Addiction Science & Clinical Practice |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s13722-025-00623-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
